CLINICAL_TRIALS
trial_result
· 2017-03-23
Clinical Trial Update: Randomized Double Blind Control Trial on Effects of Ranolazine on New Onset Atrial Fibrillation [NA]
Summary
A randomized double-blind trial evaluating ranolazine for new-onset atrial fibrillation was terminated; results were posted in 2017.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Northwell Health | Conditions: Atrial Fibrillation New Onset, Hemorrhage | NA | Status: TERMINATED | Results posted: 2017-03-23